Dissecting BRCA1-PALB2 Activity in DNA Repair and Development
Dissecting BRCA1-PALB2 Activity in DNA Repair and Development
批准号:
10453625
负责人:
Neil Johnson
金额:
$40.83万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-05 至 2024-07-31
关键词:
AddressAllelesAmino AcidsBRCA1 MutationBRCA1 ProteinBRCA1 geneBRCA2 MutationBRCA2 geneBindingBiochemicalBiological AssayBreastCellsCessation of lifeCharacteristicsChromatinCoiled-Coil DomainComplexDNADNA DamageDNA Double Strand BreakDNA RepairDNA Repair PathwayDefectDevelopmentDiseaseEmbryoEmbryonic DevelopmentFanconi&aposs AnemiaFilamentGenetic EpistasisGenomeGenomic InstabilityGoalsHealthHeterodimerizationHuman Cell LineImmunoprecipitationKineticsKnock-outLaboratoriesLinkMaintenanceMalignant NeoplasmsMalignant neoplasm of ovaryMediatingMolecularMusMutant Strains MiceMutationNaturePALB2 genePatientsPeptidesPhenotypeProteinsRecruitment ActivityRoleSiteStructureSystemTertiary Protein StructureUnited StatesWorkbasedevelopmental diseaseexperimental studygenome integrityhomologous recombinationinsightmalignant breast neoplasmmouse geneticsmouse modelmutant mouse modelmutation carrierneonatal micenovelpostnatal developmentpreventprotein complexrecruitubiquitin ligaseubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The BRCA1 and PALB2 proteins directly heterodimerize through their respective coiled-coil (CC) domains,
facilitating the formation of a larger BRCA1-PALB2-BRCA2-RAD51 complex that is required for RAD51 filament
formation. Currently, little is known about the structural basis of the BRCA1-PALB2 interaction, including the
residue alignment and orientation of physically interacting -helices. Elucidating CC molecular interactions is
critical for understanding how mutations found in patients disrupt peptide interactions and promote disease.
Protein CC domains are capable of mediating interactions with several CC domain containing partners. However,
BRCA1 and PALB2 form the only known interaction that is mediated by their respective CC domains. Whether
BRCA1 and PALB2 CC domains exclusively interact with one another, or if there are additional CC interactions
and functions is unknown. Our laboratory has developed novel BRCA1 and PALB2 CC domain mutant mouse
models to investigate the significance of this interaction in DNA repair and organismal health. We have also
purified CC peptides so that biochemical assays can be performed assessing the effects of mutations on complex
interactions and activity. The only known function of BRCA1 and PALB2 CC domains is to interact with one
another, thus, BRCA1CC and PALB2CC homozygous mice might be expected to have identical phenotypes.
However, while BRCA1CC mice are born at sub-Mendelian ratios and neo-natal mice demonstrate a range of
developmental defects, PALB2CC homozygosity resulted in early embryonic lethality. Because BRCA1CC and
PALB2CC mice have distinct phenotypes, we hypothesize that CC domains facilitate protein interactions beyond
the BRCA1-PALB2 heterodimer that promote DNA repair and embryonic development. We will address the
following Specific Aims: 1) Determine biochemical CC interactions and activity; 2) Uncover DNA repair and
developmental defects in CC mutant mice; and 3) Elucidate mechanisms of BRCA1-PALB2 complex recruitment
to DNA breaks. Collectively, the proposed experiments will yield new insight into the mechanism by which the
BRCA1-PALB2 complex protects from genome instability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Assessing DNA polymerase theta as a therapeutic target in BRCA1 mutant cancer
-
批准号:10446399
-
项目类别:
-
资助金额:$43.01万
-
财政年份:2022
-
负责人:Neil Johnson
-
依托单位:
Assessing DNA Polymerase Theta as a Therapeutic Target in BRCA1 Mutant Cancer
-
批准号:10884036
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2022
-
负责人:Neil Johnson
-
依托单位:
Assessing DNA polymerase theta as a therapeutic target in BRCA1 mutant cancer
-
批准号:10579323
-
项目类别:
-
资助金额:$42.14万
-
财政年份:2022
-
负责人:Neil Johnson
-
依托单位:
Dissecting BRCA1-PALB2 Activity in DNA Repair and Development
-
批准号:10664883
-
项目类别:
-
资助金额:$38.66万
-
财政年份:2020
-
负责人:Neil Johnson
-
依托单位:
Dissecting BRCA1-PALB2 Activity in DNA Repair and Development
-
批准号:10229611
-
项目类别:
-
资助金额:$42.9万
-
财政年份:2020
-
负责人:Neil Johnson
-
依托单位:
The role of microhomology-mediated end joining in Fanconi anemia pathogenesis
-
批准号:10580006
-
项目类别:
-
资助金额:$46.75万
-
财政年份:2020
-
负责人:Neil Johnson
-
依托单位:
Dissecting BRCA1-PALB2 Activity in DNA Repair and Development
-
批准号:10388570
-
项目类别:
-
资助金额:$22.9万
-
财政年份:2020
-
负责人:Neil Johnson
-
依托单位:
The role of microhomology-mediated end joining in Fanconi anemia pathogenesis
-
批准号:10367981
-
项目类别:
-
资助金额:$45.41万
-
财政年份:2020
-
负责人:Neil Johnson
-
依托单位:
Compensatory mechanisms that promote homologous recombination in BRCA1 mutant cancers
-
批准号:10242152
-
项目类别:
-
资助金额:$42.78万
-
财政年份:2019
-
负责人:Neil Johnson
-
依托单位:
Compensatory mechanisms that promote homologous recombination in BRCA1 mutant cancers
-
批准号:9762056
-
项目类别:
-
资助金额:$41.49万
-
财政年份:2019
-
负责人:Neil Johnson
-
依托单位:
Compensatory mechanisms that promote homologous recombination in BRCA1 mutant cancers
-
批准号:9397651
-
项目类别:
-
资助金额:$41.86万
-
财政年份:2017
-
负责人:Neil Johnson
-
依托单位:
Identifying BRCA1 protein variants that provide resistance to therapy
-
批准号:9036352
-
项目类别:
-
资助金额:$23.29万
-
财政年份:2015
-
负责人:Neil Johnson
-
依托单位:
海外基金